🏔️ Independent health resource — See all topics

NAD+ vs NR: Which Has More Research?

NAD+ vs NR: Which Has More Research?

SM
Reviewed by Dr. Sarah Mitchell, MD
Updated March 2026 · 10 min read
Quick Answer
NAD+ is the active coenzyme your cells use; NR (Nicotinamide Riboside) is a precursor that converts to NAD+ in two steps. NR has the most published human clinical trials of any NAD+ precursor and is the active ingredient in popular supplements like Tru Niagen. Both effectively raise NAD+ levels—NAD+ IV offers the highest peak levels; NR provides well-researched, affordable oral supplementation for daily use.
Key Takeaways
  • NAD+ is the active molecule — The coenzyme cells actually use for energy and repair
  • NR is a precursor — Converts to NAD+ in two steps (NR → NMN → NAD+)
  • NR has the most human research — More published clinical trials than NMN or direct NAD+
  • Different delivery methods — NAD+ via IV/injection; NR via oral supplements
  • Cost differs substantially — NAD+ IV: $250-$1,500/session; NR: $40-$80/month
  • Both work — Choose based on goals, budget, and preference for research backing

NAD+

Active coenzyme

  • IV or injection delivery
  • ~100% bioavailability
  • $250-$1,500/session
  • Immediate effects
  • Growing research base
VS

NR

Most-researched precursor

  • Oral supplement
  • Variable absorption
  • $40-$80/month
  • Gradual effects over weeks
  • Extensive clinical trials

What Is NR (Nicotinamide Riboside)?

NR (Nicotinamide Riboside) is a form of vitamin B3 that serves as an NAD+ precursor. Your body converts NR into NAD+ through two enzymatic steps:

NR Conversion Pathway: NR → NMN → NAD+ (2 steps)

NR was identified as an NAD+ precursor in 2004, and since then it has become one of the most heavily researched longevity supplements on the market. It’s the active ingredient in Tru Niagen (made by ChromaDex) and Elysium Basis—two of the most popular and well-established NAD+ boosting supplements.

What Makes NR Special?

NR stands out among NAD+ precursors for several reasons:

  • Most clinical research — NR has more published human clinical trials than any other NAD+ precursor, including NMN
  • Proven to increase NAD+ — Multiple randomized controlled trials confirm NR supplementation raises blood NAD+ levels
  • Well-characterized safety — Long-term safety data available from clinical studies
  • Patented forms — Niagen (ChromaDex’s patented NR) undergoes rigorous quality control
  • Available without prescription — Sold as a dietary supplement

The research advantage is real: if clinical evidence is your primary decision factor, NR currently has the strongest track record among oral NAD+ boosters.

What Is NAD+?

NAD+ (Nicotinamide Adenine Dinucleotide) is the active coenzyme that NR eventually becomes. It’s involved in over 500 enzymatic reactions, including energy production (converting food to ATP), DNA repair, sirtuin activation (proteins linked to longevity), and cellular signaling.

NAD+ levels decline approximately 50% by age 60. This decline correlates with reduced energy, slower recovery, and various age-related issues.

When you receive NAD+ therapy via IV or injection, you’re getting the finished molecule directly—no conversion required. This produces higher peak NAD+ levels than any oral precursor can achieve. For details, see our complete NAD+ guide.

Key Differences: NAD+ vs NR

FactorNAD+ (Direct)NR (Precursor)
What it isActive coenzymeB3 vitamin / precursor
Steps to NAD+0 (already NAD+)2 enzymatic steps
DeliveryIV, injectionOral supplement
Bioavailability~100% (IV)Variable (oral)
Human researchGrowingMost extensive of precursors
Monthly cost$250-$1,500+$40-$80
Time to effectHours2-4 weeks
Popular brandsVarious clinicsTru Niagen, Elysium Basis

Research Comparison

NR Research (Extensive)

NR has accumulated the most published human clinical trial data of any NAD+ precursor. Key studies include:

2018 – Martens et al. (Nature Communications):

  • First placebo-controlled trial in healthy middle-aged and older adults
  • 1000mg NR daily for 6 weeks
  • NAD+ levels increased ~60% from baseline
  • Well-tolerated with no serious adverse events

2017 – Airhart et al. (PLoS One):

  • Pharmacokinetics study showing NR is absorbed and raises NAD+ metabolites in humans
  • Established dosing parameters for future trials

2019 – Conze et al. (Scientific Reports):

  • Long-term safety evaluation of Niagen NR
  • Demonstrated safety at recommended doses over extended periods
  • No significant adverse effects compared to placebo

2020+ studies: Multiple additional trials have examined NR for cardiovascular health, cognitive function, muscle performance, and metabolic health—with more ongoing.

NAD+ IV Research (Growing)

NAD+ IV therapy has less published clinical trial data, though research is expanding:

  • 2019 pilot study: 6-hour IV NAD+ infusion substantially increased plasma NAD+ levels in healthy adults—immediate and measurable effects
  • Clinical use data: NAD+ IV has been used in addiction treatment settings since the 1960s (the “NAD+ detox” protocol), with observational data but fewer controlled trials
  • Ongoing trials: Several clinical trials examining NAD+ IV for specific applications are currently underway

Bottom line on research: If having the most clinical evidence matters to you, NR currently has the advantage. NAD+ IV research is growing but hasn’t yet matched the volume of NR trials.

Effectiveness Comparison

Both NR and NAD+ effectively raise NAD+ levels—but through different mechanisms with different characteristics.

NAD+ (IV/Injection)

  • Peak levels: Highest achievable NAD+ concentrations
  • Speed: Effects within hours of infusion
  • Bioavailability: ~100% (IV) or 80-90% (injection)
  • Duration: Elevated levels may persist days to weeks, then decline
  • Experience: Often intense—people report immediate energy, clarity, sometimes side effects during infusion

NR (Oral Supplements)

  • Peak levels: Moderate elevation (1000mg/day → ~60% increase in studies)
  • Speed: Gradual increase over 2-4 weeks
  • Bioavailability: Variable, but absorption confirmed in human studies
  • Duration: Sustained with daily dosing; levels decline after stopping
  • Experience: Subtle—most people notice improved energy and endurance over weeks, not dramatic immediate effects

The 2018 Martens study showed NR (1000mg daily) increased blood NAD+ by approximately 60% after 6 weeks. IV NAD+ produces higher absolute peaks, but NR provides consistent, sustained elevation that many find sufficient for general wellness goals.

Learn About NAD+ IV Therapy

Higher peaks, faster effects—see the complete guide.

Read IV Therapy Guide →

Cost Comparison

OptionMonthly CostAnnual Cost
NAD+ IV therapy$500-$1,500$6,000-$18,000
NAD+ injections$50-$350$600-$4,200
NR supplements (Tru Niagen)$40-$50$480-$600
NR supplements (Elysium)$50-$60$600-$720

NR supplements cost roughly 10-30x less annually than regular NAD+ IV therapy. This makes NR the practical choice for most people seeking long-term NAD+ support without major financial commitment.

Tru Niagen (ChromaDex)

  • Most researched NR brand
  • 300mg per capsule (standard dose: 300-600mg daily)
  • Uses patented Niagen NR
  • ~$47/month with subscription
  • Third-party tested

Elysium Basis

  • Combines NR with pterostilbene (a resveratrol-like compound)
  • Created by MIT researchers
  • 250mg NR + 50mg pterostilbene per serving
  • ~$60/month with subscription
  • Some research specific to their formulation

Both are reputable options. Tru Niagen has more total published research using their specific ingredient; Elysium argues their combination formula offers synergistic benefits.

Which Should You Choose?

Choose NAD+ (IV/Injection) If:

  • You want maximum peak NAD+ levels — IV delivers the highest concentrations
  • You have acute needs — Recovery, athletic performance peaks, specific protocols
  • Budget allows — You can afford ongoing sessions without financial strain
  • You want immediate effects — IV works within hours, not weeks
  • You prefer clinical supervision — Some people value medical oversight

Choose NR Supplements If:

  • Research backing matters to you — NR has the most published human trials
  • You want affordable long-term maintenance — ~$50/month vs. $500+/session
  • Convenience is important — Daily pill vs. clinic visits
  • You’re new to NAD+ boosting — Lower commitment to start
  • You prefer established brands — Tru Niagen and Elysium have long track records

NR vs NMN Note

Both NR and NMN are effective oral NAD+ precursors. NR is two steps from NAD+; NMN is one step. NR has more published human research; NMN has a dedicated cellular transporter. Many experts consider them roughly equivalent for practical purposes. See our NMN vs NR comparison for detailed analysis.

Frequently Asked Questions

For long-term maintenance, NR is effective and well-researched. However, it won’t produce the immediate high peaks of IV NAD+. They serve different purposes: NR for daily maintenance with gradual benefits; IV NAD+ for intensive protocols with immediate effects. Many people use both—IV for periodic boosts, NR for ongoing support.
Most people notice effects after 2-4 weeks of consistent daily use. Studies show measurable NAD+ increases within 2 weeks, with continued improvement through 6-8 weeks. Unlike IV NAD+ (which produces effects within hours), NR’s benefits develop gradually as NAD+ levels build up.
Neither is definitively better. NR has more published human clinical trials. NMN is one step closer to NAD+ and has a dedicated cellular transporter (Slc12a8). Both effectively raise NAD+ levels. Many experts consider them roughly equivalent—the best choice depends on your preference for research backing vs. biochemical pathway.
Yes. A common protocol is periodic NAD+ IV sessions (loading or boosts) combined with daily NR supplements for ongoing maintenance. No evidence of harm from combining—you’re just supporting NAD+ levels through multiple pathways.
Tru Niagen is the most researched NR supplement brand, made by ChromaDex. It contains patented Niagen (nicotinamide riboside chloride) and has been used in multiple published clinical trials. It’s available without prescription and third-party tested for quality.
NR is generally well-tolerated. Published trials report no serious adverse effects at recommended doses. Some people experience mild GI upset initially, especially at higher doses. Taking NR with food often helps. Long-term safety data from clinical studies is reassuring.

The Bottom Line

NAD+ and NR both effectively raise NAD+ levels, but they’re suited for different situations:

  • NAD+ (IV/injection): Direct delivery of the active molecule, highest peak levels, immediate effects—but expensive and requires clinical access
  • NR (supplements): The most-researched oral precursor, affordable, convenient, well-tolerated—gradual effects over weeks rather than hours

For most people seeking long-term NAD+ support with strong research backing and reasonable cost, NR supplements like Tru Niagen are an excellent choice. For maximum intensity and immediate effects regardless of cost, NAD+ IV delivers. Many longevity-focused individuals use both: periodic IV NAD+ for boosts, daily NR for maintenance.

Compare All NAD+ Options

See IV, injections, and all supplements side by side.

View Complete Guide →

References

  1. Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286.
  2. Airhart SE, Shireman LM, Risler LJ, et al. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. PLoS One. 2017;12(12):e0186459.
  3. Conze D, Brenner C, Kruger CL. Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults. Sci Rep. 2019;9(1):9772.
  4. Trammell SA, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016;7:12948.
Editorial Standards: Reviewed by a licensed healthcare professional. Recommendations based on published clinical research. Editorial policy.